Healthcare -
Biotechnology - NASDAQ - US
$ 1.475
3.4 %
$ 22.1 M
Market Cap
-0.58
P/E
LGVN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity LGVN - Longeveron Inc.
25.6 M
LAST VALUE
-3.44%
2 YEAR CAGR
19.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR